08.31.22
Silab won two awards in two weeks for its regenerating anti-aging active ingredient, Regenixir. Earlier this month, Regenixir was recognized by the Chinese beauty industry with the Ringier Technology Innovation Award in the effective ingredients category and the ICIC Award in the technology innovation ingredient category.
“We are very pleased to receive these two distinctions, which highlight the high level of scientific expertise in our Regenixir product," said Brigitte Closs-Gonthier, deputy general manager for innovation. "For this anti-aging active ingredient of biotechnological origin, we acquired new technological expertise through the establishment of partnerships with two prestigious international research laboratories.”
Closs-Gonthier added that the awards are the result of Silab's innovation strategy and investment policy—20% of sales is devoted to R&D each year. The active ingredient category is one of the fastest-growing segments in skincare.
To demonstrate the efficacy of Regenixir, Silab set up a novel modeling study made possible by the integration in-house of skills required to develop innovative vascularized models and innovative models of immune cells. The company demonstrated for the first time that the interconnectivity of the cutaneous, vascular and immune systems, required in the skin regeneration process, is weakened during aging. By revitalizing cellular interconnectivity, Regenixir enables the rapid and overall regeneration of mature skin, according to Silab.
Exports account for 60% of Silab sales. The company maintains that this recognition testifies to its ability to offer comprehensive solutions that meet the needs of consumers in the global cosmetics industry.
“We are very pleased to receive these two distinctions, which highlight the high level of scientific expertise in our Regenixir product," said Brigitte Closs-Gonthier, deputy general manager for innovation. "For this anti-aging active ingredient of biotechnological origin, we acquired new technological expertise through the establishment of partnerships with two prestigious international research laboratories.”
Closs-Gonthier added that the awards are the result of Silab's innovation strategy and investment policy—20% of sales is devoted to R&D each year. The active ingredient category is one of the fastest-growing segments in skincare.
To demonstrate the efficacy of Regenixir, Silab set up a novel modeling study made possible by the integration in-house of skills required to develop innovative vascularized models and innovative models of immune cells. The company demonstrated for the first time that the interconnectivity of the cutaneous, vascular and immune systems, required in the skin regeneration process, is weakened during aging. By revitalizing cellular interconnectivity, Regenixir enables the rapid and overall regeneration of mature skin, according to Silab.
Exports account for 60% of Silab sales. The company maintains that this recognition testifies to its ability to offer comprehensive solutions that meet the needs of consumers in the global cosmetics industry.